BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31777596)

  • 41. Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.
    Jin W; Xu HX; Zhang SR; Li H; Wang WQ; Gao HL; Wu CT; Xu JZ; Qi ZH; Li S; Ni QX; Liu L; Yu XJ
    Ann Surg Oncol; 2019 Feb; 26(2):635-643. PubMed ID: 30374923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.
    Nakagawa K; Sho M; Akahori T; Nagai M; Nakamura K; Takagi T; Tanaka T; Nishiofuku H; Ohbayashi C; Kichikawa K; Ikeda N
    Pancreatology; 2019 Jul; 19(5):722-728. PubMed ID: 31153778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
    Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
    BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Refining the American Joint Committee on Cancer Staging Scheme For Resectable Pancreatic Ductal Adenocarcinoma Using Recursive Partitioning Analysis.
    Jiang Y; Su Y; Chen Y; Li Z
    J Cancer; 2017; 8(14):2765-2773. PubMed ID: 28928865
    [No Abstract]   [Full Text] [Related]  

  • 46. Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma.
    Gu X; Zhou R; Li C; Liu R; Zhao Z; Gao Y; Xu Y
    BMC Cancer; 2019 May; 19(1):456. PubMed ID: 31092213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection.
    Fu Y; Yang X; Liang H; Wu X
    Cancer Manag Res; 2019; 11():5091-5100. PubMed ID: 31213920
    [No Abstract]   [Full Text] [Related]  

  • 49. A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms.
    Zhang S; Tong YX; Zhang XH; Zhang YJ; Xu XS; Xiao AT; Chao TF; Gong JP
    J Cancer; 2019; 10(24):5944-5954. PubMed ID: 31762804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multimodal survival prediction in advanced pancreatic cancer using machine learning.
    Keyl J; Kasper S; Wiesweg M; Götze J; Schönrock M; Sinn M; Berger A; Nasca E; Kostbade K; Schumacher B; Markus P; Albers D; Treckmann J; Schmid KW; Schildhaus HU; Siveke JT; Schuler M; Kleesiek J
    ESMO Open; 2022 Oct; 7(5):100555. PubMed ID: 35988455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphocyte-to-Monocyte Ratio and Prognostic Nutritional Index Predict Poor Prognosis in Patients on Chemotherapy for Unresectable Pancreatic Cancer.
    Shimizu T; Taniguchi K; Asakuma M; Tomioka A; Inoue Y; Komeda K; Hirokawa F; Uchiyama K
    Anticancer Res; 2019 Apr; 39(4):2169-2176. PubMed ID: 30952764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.
    Ikuta S; Aihara T; Yamanaka N
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e109-e114. PubMed ID: 30632282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
    Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nomogram prediction for the survival of the patients with small cell lung cancer.
    Pan H; Shi X; Xiao D; He J; Zhang Y; Liang W; Zhao Z; Guo Z; Zou X; Zhang J; He J
    J Thorac Dis; 2017 Mar; 9(3):507-518. PubMed ID: 28449457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
    Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review.
    Ahmad J; Grimes N; Farid S; Morris-Stiff G
    Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):474-81. PubMed ID: 25308357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
    Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
    Front Oncol; 2020; 10():341. PubMed ID: 32219070
    [No Abstract]   [Full Text] [Related]  

  • 59. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients.
    Lin JX; Tang YH; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH; Xie JW
    World J Gastroenterol; 2019 Nov; 25(41):6258-6272. PubMed ID: 31749596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer.
    Cho U; Park HS; Im SY; Yoo CY; Jung JH; Suh YJ; Choi HJ
    PLoS One; 2018; 13(7):e0200936. PubMed ID: 30048474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.